|
|
|
Volumn 90, Issue 1, 2005, Pages
|
|
Myeloablative conditioning in myelofibrosis using i.v. treosulfan and autologous peripheral blood progenitor cell transplantation with high doses of CD34+ cells results in hematologic responses. A follow-up of three patients.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALKYLATING AGENT;
BUSULFAN;
CD34 ANTIGEN;
DRUG DERIVATIVE;
TREOSULFAN;
MYELOABLATIVE AGENT;
ARTICLE;
AUTOTRANSPLANTATION;
BLOOD;
CASE REPORT;
FEMALE;
FOLLOW UP;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
METHODOLOGY;
MYELOFIBROSIS;
PERIPHERAL BLOOD STEM CELL TRANSPLANTATION;
ANALOGS AND DERIVATIVES;
BIOSYNTHESIS;
INTRAVENOUS DRUG ADMINISTRATION;
MIDDLE AGED;
PRIMARY MYELOFIBROSIS;
PROCEDURES;
TRANSPLANTATION CONDITIONING;
TREATMENT OUTCOME;
ANTIGENS, CD34;
ANTINEOPLASTIC AGENTS, ALKYLATING;
BUSULFAN;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
MYELOFIBROSIS;
PERIPHERAL BLOOD STEM CELL TRANSPLANTATION;
TRANSPLANTATION CONDITIONING;
TRANSPLANTATION, AUTOLOGOUS;
INFUSIONS, INTRAVENOUS;
MIDDLE AGED;
MYELOABLATIVE AGONISTS;
PRIMARY MYELOFIBROSIS;
TREATMENT OUTCOME;
|
|
EID: 84991238547
PISSN: None
EISSN: 15928721
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (6)
|
|
References (0)
|
